In vitro metabolism of the new antifungal dapaconazole using liver microsomes.
Cytochrome P450
Dapaconazole
In vitro metabolism
LC-MS/MS
Microsomes
Journal
Drug metabolism and pharmacokinetics
ISSN: 1880-0920
Titre abrégé: Drug Metab Pharmacokinet
Pays: England
ID NLM: 101164773
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
25
04
2022
revised:
26
06
2022
accepted:
08
09
2022
pubmed:
13
11
2022
medline:
6
12
2022
entrez:
12
11
2022
Statut:
ppublish
Résumé
Dapaconazole is a new antifungal imidazole that has been shown a high efficacy against several pathogenic fungi. This study aimed to investigate the interspecies variation in the in vitro metabolic profiles and in vivo hepatic clearance (CL
Identifiants
pubmed: 36370616
pii: S1347-4367(22)00032-5
doi: 10.1016/j.dmpk.2022.100475
pii:
doi:
Substances chimiques
Antifungal Agents
0
1-(2-(2,4-dichlorophenyl)-2-(4-(trifluoromethyl)benzyloxy)ethyl)-1H-imidazole
0
Imidazoles
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
100475Informations de copyright
Copyright © 2022 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare no conflicts of interest.